Abstract:Merging pharmaceutical and digital (mobile health, mHealth) ingredients to create new therapies for chronic diseases offers unique opportunities for natural products such as omega-3 polyunsaturated fatty acids (n-3 PUFA), curcumin, resveratrol, theanine, or α-lipoic acid. These compounds, when combined with pharmaceutical drugs, show improved efficacy and safety in preclinical and clinical studies of epilepsy, neuropathic pain, osteoarthritis, depression, schizophrenia, diabetes and cancer. Their additional clinical benefits include reducing levels of TNFα and other inflammatory cytokines. We describe how pleiotropic natural products can be developed as bioactive incentives within the network pharmacology together with pharmaceutical drugs and self-care interventions. Since approximately 50% of chronically-ill patients do not take pharmaceutical drugs as prescribed, psychobehavioral incentives may appeal to patients at risk for medication non-adherence. For epilepsy, the incentive-based network therapy comprises anticonvulsant drugs, antiseizure natural products (n-3 PUFA, curcumin or/and resveratrol) coupled with disease-specific behavioral interventions delivered by mobile medical apps. The add-on combination of antiseizure natural products and mHealth supports patient empowerment and intrinsic motivation by having a choice in self-care behaviors. The incentivized therapies offer opportunities: (1) to improve clinical efficacy and safety of existing drugs, (2) to catalyze patient-centered, disease self-management and behavior-changing habits, also improving health-related quality-of-life after reaching remission, and (3) merging copyrighted mHealth software with natural products, thus establishing an intellectual property protection of medical treatments comprising the natural products existing in public domain and currently promoted as dietary supplements. Taken together, clinical research on synergies between existing drugs and pleiotropic natural products, and their integration with self-care, music and mHealth, expands precision/personalized medicine strategies for chronic diseases via pharmacological-behavioral combination therapies.
Fiber metal laminate (FML) is a kind of lightweight material with excellent mechanical properties combining advantages of metal laminates and fiber reinforced composites. It has been widely used in the aerospace and transportation fields and is especially used as structural material such as aircraft skins, wings, and tails. However, under complex service conditions, interlaminar failure in FMLs greatly reduced mechanical properties of the material, even leading to serious economic and safety disasters. The failure and destruction of important structural parts of aircraft and other manned transportation vehicles are extremely unsafe for people. Therefore, it is of great significance to summarize the interlaminar failure behavior of FMLs and find ways to avoid these defects. This review paper is a collection of various researches done by many groups, which systematically discuss the interlaminar failure behaviors and their control methods of FMLs. The application status of several common FMLs in aircraft structures was given. The common interlaminar failure modes of FMLs and the testing and evaluation methods of interlaminar properties were stated. The failure mechanisms and the corresponding control methods were analyzed. Finally, the future developments of FMLs were also discussed by the authors. Through this review article, readers can obtain new research progress about the control method, the mechanism and future development on the failure behavior of FMLs in a more efficient way.
Highlights This article firstly reviews the urban traffic situation from 1/23/2020 to 3/8/2020 in China. Between cities, blocking and controlling the traffic are urgent in the early stage of epidemic. Inside a city, it is urgent to suspend the public transports, block roads, restrict private cars. We also give suggestions about the long-term planning and improvement methods. This article offers a valuable reference of urban traffic control now and in the future.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.